Skip to content

Clinical trials

Withdrawn Phase 3 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Withdrawn Country / region: South Korea Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20114
20121
20132
20143
20152
20161
20171
20181
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital5
Asan Medical Center2
Bristol-Myers Squibb2
Celgene2
Samsung Medical Center2
AstraZeneca1
Centocor, Inc.1
Gangnam Severance Hospital1
Inje University1
Janssen Infectious Diseases BVBA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence4
Multiple Myeloma2
Stomach Neoplasms2
Acute Pain1
Ascites1
Bile Duct Neoplasms1
COVID-191
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.